MiMedx Group Inc/ US6024961012 /
2024-11-11 4:57:49 PM | Chg. +0.1000 | Volume | Bid5:00:17 PM | Ask5:00:17 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.6300USD | +1.33% | 161,291 Turnover: 1.01 mill. |
7.6200Bid Size: 700 | 7.6300Ask Size: 800 | 1.12 bill.USD | - | 18.98 |
GlobeNewswire
07-22
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allograft...
GlobeNewswire
07-17
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other ...
GlobeNewswire
07-17
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
GlobeNewswire
05-16
Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of...
GlobeNewswire
04-16
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
GlobeNewswire
03-21
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial R...
GlobeNewswire
02-28
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
GlobeNewswire
02-12
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on ...
GlobeNewswire
01-26
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, In...
GlobeNewswire
01-26
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages MiMedx Group, Inc. Investors to Inquire About Secur...